1. Zaidan H, Ramaswami G, Barak M, Li JB, Gaisler-Salomon I. Pre-reproductive stress and fluoxetine treatment in rats affect offspring A-to-I RNA editing, gene expression and social behavior. Environmental Epigenetics. (Accepted).

2. Zaidan H, Ramaswami G, Golumbic YN, Sher N, Malik A, Barak M, Galiani D, Dekel N, Li JB, Gaisler-Salomon I. A-to-I RNA editing in the rat brain is age-dependent, region-specific and sensitive to environmental stress across generations. BMC genomics. 2018 Dec;19(1):28.

3. Lander SS, Khan U, Lewandowski N, Chakraborty D, Provenzano FA, Mingote S, Chornyy S, Frigerio F, Maechler P, Kaphzan H, Small SA. Glutamate Dehydrogenase–Deficient Mice Display Schizophrenia-Like Behavioral Abnormalities and CA1-Specific Hippocampal Dysfunction. Schizophrenia bulletin. 2018 Feb 20.

4. Lander SS, Linder-Shacham D, Gaisler-Salomon I. Differential effects of social isolation in adolescent and adult mice on behavior and cortical gene expression. Behav Brain Res. 2017 Jan 1;316:245-254. doi: 10.1016/j.bbr.2016.09.005. Epub 2016 Sep 13. PubMed PMID: 27618762.

5. Braun K, Bock J, Wainstock T, Matas E, Gaisler-Salomon I, Fegert J, Ziegenhain U, Segal M. Experience-induced transgenerational (re-)programming of neuronal structure and functions: Impact of stress prior and during pregnancy. Neuroscience & Biobehavioral Reviews. 2017 May 29.

6. Mitchell AC, Javidfar B, Bicks LK, Neve R, Garbett K, Lander SS, Mirnics K, Morishita H, Wood MA, Jiang Y, Gaisler-Salomon I, Akbarian S. Longitudinal assessment of neuronal 3D genomes in mouse prefrontal cortex. Nat Commun. 2016 Sep 6;7:12743. doi: 10.1038/ncomms12743. PubMed PMID: 27597321; PubMed Central PMCID: PMC5025847.

7. Mingote S, Masson J, Gellman C, Thomsen GM, Lin CS, Merker RJ, Gaisler-Salomon I, Wang Y, Ernst R, Hen R, Rayport S. Genetic Pharmacotherapy as an Early CNS Drug Development Strategy: Testing Glutaminase Inhibition for Schizophrenia Treatment in Adult Mice. Front Syst Neurosci. 2016 Jan 8;9:165. doi: 10.3389/fnsys.2015.00165. eCollection 2015. PubMed PMID: 26778975; PubMed Central PMCID: PMC4705219.

8. Brande-Eilat N, Golumbic YN, Zaidan H, Gaisler-Salomon I. Acquisition of conditioned fear is followed by region-specific changes in RNA editing of glutamate receptors. Stress. 2015;18(3):309-18. doi: 10.3109/10253890.2015.1073254. PubMed PMID: 26383032.

9. Zaidan H, Gaisler-Salomon I. Prereproductive stress in adolescent female rats affects behavior and corticosterone levels in second-generation offspring. Psychoneuroendocrinology. 2015 Aug;58:120-9. doi: 10.1016/j.psyneuen.2015.04.013. Epub 2015 Apr 24. PubMed PMID: 25973567.

10. Hazan L, Gaisler-Salomon I. Glutaminase1 heterozygous mice show enhanced trace fear conditioning and Arc/Arg3.1 expression in hippocampus and cingulate cortex. Eur Neuropsychopharmacol. 2014 Dec;24(12):1916-24. doi: 10.1016/j.euroneuro.2014.10.003. Epub 2014 Oct 18. PubMed PMID: 25453483.

11. Bock J, Poeschel J, Schindler J, Börner F, Shachar-Dadon A, Ferdman N, Gaisler-Salomon I, Leshem M, Braun K, Poeggel G. Transgenerational sex-specific impact of preconception stress on the development of dendritic spines and dendritic length in the medial prefrontal cortex. Brain Struct Funct. 2016 Mar;221(2):855-63. doi: 10.1007/s00429-014-0940-4. Epub 2014 Nov 14. PubMed PMID: 25395153.

12. Gaisler-Salomon I, Kravitz E, Feiler Y, Safran M, Biegon A, Amariglio N, Rechavi G. Hippocampus-specific deficiency in RNA editing of GluA2 in Alzheimer's disease. Neurobiol Aging. 2014 Aug;35(8):1785-91. doi: 10.1016/j.neurobiolaging.2014.02.018. Epub 2014 Mar 1. PubMed PMID: 24679603.

13. Kravitz E, Gaisler-Salomon I, Biegon A. Hippocampal glutamate NMDA receptor loss tracks progression in Alzheimer's disease: quantitative autoradiography in postmortem human brain. PLoS One. 2013 Nov 28;8(11):e81244. doi: 10.1371/journal.pone.0081244. eCollection 2013. PubMed PMID: 24312282; PubMed Central PMCID: PMC3842934.

14. Zaidan H, Leshem M, Gaisler-Salomon I. Prereproductive stress to female rats alters corticotropin releasing factor type 1 expression in ova and behavior and brain corticotropin releasing factor type 1 expression in offspring. Biol Psychiatry. 2013 Nov 1;74(9):680-7. doi: 0.1016/j.biopsych.2013.04.014. Epub 2013 May 29. PubMed PMID: 23726318.

15. Mihali A, Subramani S, Kaunitz G, Rayport S, Gaisler-Salomon I. Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery. Expert Rev Neurother. 2012 Jul;12(7):785-99. doi: 10.1586/ern.12.60. Review. PubMed PMID: 22853787; PubMed Central PMCID: PMC3509194.

16. Gaisler-Salomon I, Wang Y, Chuhma N, Zhang H, Golumbic YN, Mihali A, Arancio O, Sibille E, Rayport S. Synaptic underpinnings of altered hippocampal function in glutaminase-deficient mice during maturation. Hippocampus. 2012 May;22(5):1027-39. doi: 10.1002/hipo.22014. Epub 2012 Mar 19. PubMed PMID: 22431402; PubMed Central PMCID: PMC3531559.

17. Gaisler-Salomon I, Schobel SA, Small SA, Rayport S. How high-resolution basal-state functional imaging can guide the development of new pharmacotherapies for schizophrenia. Schizophr Bull. 2009 Nov;35(6):1037-44. doi: 10.1093/schbul/sbp114. Epub 2009 Oct 14. PubMed PMID: 19828591; PubMed Central PMCID: PMC2762634.

18. Gaisler-Salomon I, Miller GM, Chuhma N, Lee S, Zhang H, Ghoddoussi F, Lewandowski N, Fairhurst S, Wang Y, Conjard-Duplany A, Masson J, Balsam P, Hen R, Arancio O, Galloway MP, Moore HM, Small SA, Rayport S. Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia. Neuropsychopharmacology. 2009 Sep;34(10):2305-22. doi: 10.1038/npp.2009.58. Epub 2009 Jun 10. PubMed PMID: 19516252; PubMed Central PMCID: PMC2811085.

19. Gaisler-Salomon I, Diamant L, Rubin C, Weiner I. Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered. Psychopharmacology (Berl). 2008 Feb;196(2):255-67. Epub 2007 Oct 11. PubMed PMID: 17928997.

20. Weiner I, Schiller D, Gaisler-Salomon I, Green A, Joel D. A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine. Behav Pharmacol. 2003 May;14(3):215-22. PubMed PMID: 12799523.

21. Weiner I, Schiller D, Gaisler-Salomon I. Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action. Neuropsychopharmacology. 2003 Mar;28(3):499-509. Epub 2002 Sep 23. PubMed PMID: 12629529.

22. Shadach E, Gaisler I, Schiller D, Weiner I. The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin. Neuropsychopharmacology. 2000 Aug;23(2):151-61. PubMed PMID: 10882841.

23. Gaisler-Salomon I, Weiner I. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol. Psychopharmacology (Berl). 2003 Apr;166(4):333-42. Epub 2003 Feb 22. PubMed PMID: 12599023.